MUMBAI (Reuters) - The president of a brokerage association is planning to formally request that market regulator SEBI investigate trading in Ranbaxy Laboratories Ltd shares in the days leading up to its acquisition by Sun Pharmaceutical Industries.
Ranbaxy
"Because there was such kind of price movement before the deal was announced, we have decided to check with the regulator," Naresh Tejwani, president of the Association of National Exchanges Members of India (ANMI) said on Wednesday.
"We will write to them by the end of the day to investigate into the matter."
A Ranbaxy spokesman declined to comment.
A spokesman for market regulator Securities and Exchange Board of India also declined to comment.
Sun Pharmaceutical did not immediately respond to requests for comment.
(Reporting by Himank Sharma; Editing by Ryan Woo)
